Randomized, placebo-controlled, double-blind glycemic control trial of novel sodium-dependent glucose cotransporter 2 inhibitor ipragliflozin in Japanese patients with type 2 diabetes mellitus.

Autor: Kashiwagi, Atsunori1, Kazuta, Kenichi2, Yoshida, Satoshi2, Nagase, Itsuro2
Zdroj: Journal of Diabetes Investigation. Jul2014, Vol. 5 Issue 4, p382-391. 10p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje